Cyclophilin A - Promising New Target in Cardiovascular Therapy -
-
- Satoh Kimio
- Aab Cardiovascular Research Institute and Department of Medicine, University of Rochester School of Medicine and Dentistry Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Shimokawa Hiroaki
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Berk Bradford C.
- Aab Cardiovascular Research Institute and Department of Medicine, University of Rochester School of Medicine and Dentistry
書誌事項
- タイトル別名
-
- – Promising New Target in Cardiovascular Therapy –
この論文をさがす
抄録
Cyclophilin A (CyPA) has been studied as a multifunctional protein that is upregulated in a variety of inflammatory conditions, such as rheumatoid arthritis, autoimmune disease, and cancer. CyPA has been classified as an immunophilin and has a variety of intracellular functions, including intracellular signaling, protein trafficking, and the regulation of other proteins activity. Besides its intracellular functions, CyPA is a secreted molecule that has a physiological and pathological role in cardiovascular diseases, making it a potential biomarker and mediator in cardiovascular diseases, such as vascular stenosis, atherosclerosis, and abdominal aortic aneurysms. (Circ J 2010; 74: 2249-2256)<br>
収録刊行物
-
- Circulation Journal
-
Circulation Journal 74 (11), 2249-2256, 2010
一般社団法人 日本循環器学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282680078665856
-
- NII論文ID
- 50007701229
- 10026972151
-
- NII書誌ID
- AA11591968
-
- COI
- 1:CAS:528:DC%2BC3cXhsFKntLvO
-
- ISSN
- 13474820
- 13469843
-
- PubMed
- 20962430
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- PubMed
- CiNii Articles
- KAKEN
-
- 抄録ライセンスフラグ
- 使用不可